Oncologix Tech (OCLG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access OCLG Annual Balance Sheets →
This balance sheet overview for Oncologix Tech spans from May 31 2014 to May 31 2015, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(May 31 2015)
(Feb 28 2015) (Nov 30 2014) (Aug 31 2014) (May 31 2014)
Assets
Cash & cash equivalent0.12
Deposit Assets0.08
Cash & Short-term Investments0.00
Accounts receivable1.04
Inventories0.14
Prepaid Expense And Other Assets Current0.00
Total Current Assets1.38
Equipment/Property/Plant Net0.04
Goodwill net2.40
Intangible Assets0.02
Other Assets, Noncurrent0.02
Total Assets3.85
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.09
Interest Payable, Current IN0.21
Notes and Loans Payable, Current LO0.10
Other Liabilities, Current3.27
Total Current Liabilities4.66
Long-term debt0.38
Convertible Debt LO0.00
Total Long-term Debt0.38
Total Liabilities5.04
Stockholders' Equity
Common Stock Value0.28
Additional Paid In Capital Common Stock48.40
Retained Earnings / Accumulated Deficit-49.86
Other Equity0.00
Common Stockholder's Equity-1.19
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-1.19
Liabilities & Stockholder's Equity3.85
4 historic quarters locked

Sign in to unlock the full Oncologix Tech balance sheet history.

About OCLG Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.